A nationwide class-action lawsuit settlement could bring payments to consumers who purchased Robitussin cough medicine products that were falsely marketed as "non-drowsy." The $4.5 million agreement, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback